Healthcare -
Biotechnology - NASDAQ - US
$ 5.31
-0.562 %
$ 165 M
Market Cap
-2.0
P/E
ACRV - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ACRV - Acrivon Therapeutics, Inc. Common Stock
21.2 M
LAST VALUE
193.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR